{"id":164774,"date":"2026-07-22T15:56:00","date_gmt":"2026-07-22T10:26:00","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=164774"},"modified":"2026-07-22T15:56:02","modified_gmt":"2026-07-22T10:26:02","slug":"jubilant-ingrevia-q1-results-fy27-pat-106-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/jubilant-ingrevia-q1-results-fy27-pat-106-crore\/","title":{"rendered":"Jubilant Ingrevia Q1 Results FY27: Net Profit Rises 40.9% to Rs 105.8 Crore on Strong Specialty Chemicals Demand"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Jubilant Ingrevia Q1 FY27: PAT Rs 105.8 Cr, up 40.9% YoY. Revenue Rs 1,300 Cr, up 25.2%. EBITDA up 39.3% at Rs 198.4 Cr, margin 15.3% vs 13.7%. Stock down 2.32% at Rs 746.10.<\/em><\/p>\n<p>Jubilant Ingrevia Q1 results FY27 were announced on Wednesday, 22 July 2026, with the company reporting the numbers summarised below on a consolidated basis for the quarter ended 30 June 2026.<\/p>\n<p>Shares of <a href=\"https:\/\/univest.in\/stocks\/jublingrea\/jubilant-ingrevia-ltd-share-price-today\">Jubilant Ingrevia<\/a> fell 2.32 to Rs 746.10 on the NSE on the results day. The specialty chemicals and nutrition and health solutions maker delivered accelerating growth across the P&amp;L, with profit growth outpacing both revenue and EBITDA.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=jubilant-ingrevia-q1-fy27-pat\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/jubilant-ingrevia-q1-results-fy27-pat-106-crore\/#Jubilant_Ingrevia_Q1_Results_FY27_Key_Takeaways\" title=\"Jubilant Ingrevia Q1 Results FY27 Key Takeaways\">Jubilant Ingrevia Q1 Results FY27 Key Takeaways<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/jubilant-ingrevia-q1-results-fy27-pat-106-crore\/#Jubilant_Ingrevia_Q1_Results_FY27_Financial_Highlights\" title=\"Jubilant Ingrevia Q1 Results FY27 Financial Highlights\">Jubilant Ingrevia Q1 Results FY27 Financial Highlights<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/jubilant-ingrevia-q1-results-fy27-pat-106-crore\/#Jubilant_Ingrevia_Q1_Results_FY27_Performance_Analysis\" title=\"Jubilant Ingrevia Q1 Results FY27 Performance Analysis\">Jubilant Ingrevia Q1 Results FY27 Performance Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/jubilant-ingrevia-q1-results-fy27-pat-106-crore\/#Jubilant_Ingrevia_Q1_Results_FY27_Key_Business_Factors\" title=\"Jubilant Ingrevia Q1 Results FY27: Key Business Factors\">Jubilant Ingrevia Q1 Results FY27: Key Business Factors<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/jubilant-ingrevia-q1-results-fy27-pat-106-crore\/#1_Broad_Based_Operating_Leverage\" title=\"1. Broad Based Operating Leverage\">1. Broad Based Operating Leverage<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/jubilant-ingrevia-q1-results-fy27-pat-106-crore\/#2_Diversified_Specialty_Chemicals_Portfolio\" title=\"2. Diversified Specialty Chemicals Portfolio\">2. Diversified Specialty Chemicals Portfolio<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/jubilant-ingrevia-q1-results-fy27-pat-106-crore\/#3_Margin_Expansion_to_153\" title=\"3. Margin Expansion to 15.3%\">3. Margin Expansion to 15.3%<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/jubilant-ingrevia-q1-results-fy27-pat-106-crore\/#Dividend_Details\" title=\"Dividend Details\">Dividend Details<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/jubilant-ingrevia-q1-results-fy27-pat-106-crore\/#Jubilant_Ingrevia_Q1_Results_FY27_Outlook_for_the_Full_Year\" title=\"Jubilant Ingrevia Q1 Results FY27 Outlook for the Full Year\">Jubilant Ingrevia Q1 Results FY27 Outlook for the Full Year<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/jubilant-ingrevia-q1-results-fy27-pat-106-crore\/#Jubilant_Ingrevia_Stock_Performance_After_the_Q1_Results\" title=\"Jubilant Ingrevia Stock Performance After the Q1 Results\">Jubilant Ingrevia Stock Performance After the Q1 Results<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/jubilant-ingrevia-q1-results-fy27-pat-106-crore\/#Key_Risks\" title=\"Key Risks\">Key Risks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/jubilant-ingrevia-q1-results-fy27-pat-106-crore\/#1_Chemicals_Sector_Cyclicality\" title=\"1. Chemicals Sector Cyclicality\">1. Chemicals Sector Cyclicality<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/jubilant-ingrevia-q1-results-fy27-pat-106-crore\/#2_Input_Cost_Volatility\" title=\"2. Input Cost Volatility\">2. Input Cost Volatility<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/jubilant-ingrevia-q1-results-fy27-pat-106-crore\/#3_Sustaining_the_Pace_of_Margin_Expansion\" title=\"3. Sustaining the Pace of Margin Expansion\">3. Sustaining the Pace of Margin Expansion<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/jubilant-ingrevia-q1-results-fy27-pat-106-crore\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/jubilant-ingrevia-q1-results-fy27-pat-106-crore\/#Frequently_Asked_Questions_on_Jubilant_Ingrevia_Q1_Results_FY27\" title=\"Frequently Asked Questions on Jubilant Ingrevia Q1 Results FY27\">Frequently Asked Questions on Jubilant Ingrevia Q1 Results FY27<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/jubilant-ingrevia-q1-results-fy27-pat-106-crore\/#When_were_the_Jubilant_Ingrevia_Q1_results_FY27_announced\" title=\"When were the Jubilant Ingrevia Q1 results FY27 announced?\">When were the Jubilant Ingrevia Q1 results FY27 announced?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/jubilant-ingrevia-q1-results-fy27-pat-106-crore\/#What_is_the_PAT_in_the_Jubilant_Ingrevia_Q1_results_FY27\" title=\"What is the PAT in the Jubilant Ingrevia Q1 results FY27?\">What is the PAT in the Jubilant Ingrevia Q1 results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/jubilant-ingrevia-q1-results-fy27-pat-106-crore\/#What_was_the_revenue_in_the_Jubilant_Ingrevia_Q1_results_FY27\" title=\"What was the revenue in the Jubilant Ingrevia Q1 results FY27?\">What was the revenue in the Jubilant Ingrevia Q1 results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/jubilant-ingrevia-q1-results-fy27-pat-106-crore\/#What_was_the_EBITDA_margin_in_the_Jubilant_Ingrevia_Q1_results_FY27\" title=\"What was the EBITDA margin in the Jubilant Ingrevia Q1 results FY27?\">What was the EBITDA margin in the Jubilant Ingrevia Q1 results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/jubilant-ingrevia-q1-results-fy27-pat-106-crore\/#What_businesses_does_Jubilant_Ingrevia_operate\" title=\"What businesses does Jubilant Ingrevia operate?\">What businesses does Jubilant Ingrevia operate?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/jubilant-ingrevia-q1-results-fy27-pat-106-crore\/#How_did_the_share_price_react_to_the_Jubilant_Ingrevia_Q1_results_FY27\" title=\"How did the share price react to the Jubilant Ingrevia Q1 results FY27?\">How did the share price react to the Jubilant Ingrevia Q1 results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/jubilant-ingrevia-q1-results-fy27-pat-106-crore\/#Is_the_stock_a_good_buy_after_the_Jubilant_Ingrevia_Q1_results_FY27\" title=\"Is the stock a good buy after the Jubilant Ingrevia Q1 results FY27?\">Is the stock a good buy after the Jubilant Ingrevia Q1 results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/jubilant-ingrevia-q1-results-fy27-pat-106-crore\/#Where_can_I_verify_the_Jubilant_Ingrevia_Q1_results_FY27\" title=\"Where can I verify the Jubilant Ingrevia Q1 results FY27?\">Where can I verify the Jubilant Ingrevia Q1 results FY27?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Jubilant_Ingrevia_Q1_Results_FY27_Key_Takeaways\"><\/span><strong>Jubilant Ingrevia Q1 Results FY27 Key Takeaways<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Here are the most important numbers from the June 2026 quarter at a glance.<\/p>\n<ul>\n<li>Revenue: Rs 1,300 Cr in Q1 FY27 versus Rs 1,038 Cr in Q1 FY26, up 25.2% year on year.<\/li>\n<li>EBITDA: Rs 198.4 Cr in Q1 FY27 versus Rs 142.4 Cr in Q1 FY26, up 39.3% year on year.<\/li>\n<li>Net Profit (PAT): Rs 105.8 Cr in Q1 FY27 versus Rs 75.1 Cr in Q1 FY26, up 40.9% year on year.<\/li>\n<li>Jubilant Ingrevia share price fell 2.32 to Rs 746.10 on the NSE on the results day.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Jubilant_Ingrevia_Q1_Results_FY27_Financial_Highlights\"><\/span><strong>Jubilant Ingrevia Q1 Results FY27 Financial Highlights<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below summarises the consolidated numbers reported in the Jubilant Ingrevia Q1 results FY27 against the year ago quarter.<\/p>\n<table>\n<thead>\n<tr>\n<th>Metric<\/th>\n<th>Q1 FY27<\/th>\n<th>Q1 FY26<\/th>\n<th>YoY Change<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Revenue<\/td>\n<td>Rs 1,300 Cr<\/td>\n<td>Rs 1,038 Cr<\/td>\n<td>+25.2%<\/td>\n<\/tr>\n<tr>\n<td>EBITDA<\/td>\n<td>Rs 198.4 Cr<\/td>\n<td>Rs 142.4 Cr<\/td>\n<td>+39.3%<\/td>\n<\/tr>\n<tr>\n<td>Net Profit (PAT)<\/td>\n<td>Rs 105.8 Cr<\/td>\n<td>Rs 75.1 Cr<\/td>\n<td>+40.9%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>All figures are on a consolidated basis as reported for the quarter ended 30 June 2026.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Jubilant_Ingrevia_Q1_Results_FY27_Performance_Analysis\"><\/span><strong>Jubilant Ingrevia Q1 Results FY27 Performance Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/sebi-registered-investment-advisor-india\"><strong>Get Personalised Guidance from a SEBI-Registered Investment Advisor<\/strong><\/a><\/p>\n<p>The Jubilant Ingrevia Q1 results FY27 show a clean pattern of operating leverage. Revenue grew 25.2%, EBITDA grew faster at 39.3%, and net profit grew fastest at 40.9%, with the EBITDA margin expanding to 15.3% from 13.7%, confirming the growth converted efficiently into profit.<\/p>\n<p>Jubilant Ingrevia operates across specialty chemicals, nutrition and health solutions, and life science chemicals, and growth of this magnitude in the Jubilant Ingrevia Q1 results FY27 likely reflects a combination of volume growth and better pricing or product mix across these segments, alongside possible input cost tailwinds supporting the margin expansion.<\/p>\n<p>The modest 2.32% stock decline despite the strong beat is a mild divergence that may reflect broader market sentiment on the results day, given the chemicals sector saw mixed reactions across several names reporting results this week.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Jubilant_Ingrevia_Q1_Results_FY27_Key_Business_Factors\"><\/span><strong>Jubilant Ingrevia Q1 Results FY27: Key Business Factors<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"1_Broad_Based_Operating_Leverage\"><\/span><strong>1. Broad Based Operating Leverage<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Revenue, EBITDA and PAT all accelerated in the Jubilant Ingrevia Q1 results FY27, from 25.2% to 39.3% to 40.9% respectively, a clean signal of margin expansion alongside genuine volume growth.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"2_Diversified_Specialty_Chemicals_Portfolio\"><\/span><strong>2. Diversified Specialty Chemicals Portfolio<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The company&#8217;s exposure across specialty chemicals, nutrition and health solutions, and life science chemicals provides some diversification against single category demand swings.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"3_Margin_Expansion_to_153\"><\/span><strong>3. Margin Expansion to 15.3%<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The EBITDA margin improving to 15.3% from 13.7% in the Jubilant Ingrevia Q1 results FY27 shows the company capturing more value per unit of revenue, whether through cost efficiency or a richer product mix.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Dividend_Details\"><\/span><strong>Dividend Details<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Any dividend announcement accompanying the June 2026 quarter results will be reflected in the company&#8217;s official NSE and BSE filings. Investors should rely on those filings for dividend confirmation rather than secondary sources.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Jubilant_Ingrevia_Q1_Results_FY27_Outlook_for_the_Full_Year\"><\/span><strong>Jubilant Ingrevia Q1 Results FY27 Outlook for the Full Year<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>After the Jubilant Ingrevia Q1 results FY27, the key question for FY27 is whether the margin expansion trajectory can continue as the specialty chemicals cycle evolves, and whether demand across the company&#8217;s diversified end markets remains supportive. Continued volume growth alongside margin discipline would extend the current trend.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Jubilant_Ingrevia_Stock_Performance_After_the_Q1_Results\"><\/span><strong>Jubilant Ingrevia Stock Performance After the Q1 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Jubilant Ingrevia live share price and upcoming quarterly results.<\/em><\/p>\n<p>Jubilant Ingrevia share price fell 2.32 to Rs 746.10 on the NSE after the Jubilant Ingrevia Q1 results FY27, as the market weighed the quarter&#8217;s numbers.<\/p>\n<p>Investors can compare the trend of the counter with the <a href=\"https:\/\/univest.in\/indices\/nifty-500\/nifty-500-share-price-today\">Nifty 500<\/a> index to judge how the stock is placed relative to the broader market after the June quarter results.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks\"><\/span><strong>Key Risks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Investors going through the fine print of the Jubilant Ingrevia Q1 results FY27 should also weigh the following risks.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"1_Chemicals_Sector_Cyclicality\"><\/span><strong>1. Chemicals Sector Cyclicality<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The specialty chemicals sector can be cyclical, tied to both domestic and export demand cycles, and the strong growth in the Jubilant Ingrevia Q1 results FY27 needs to be viewed against this backdrop.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"2_Input_Cost_Volatility\"><\/span><strong>2. Input Cost Volatility<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>As a chemicals manufacturer, the company remains exposed to raw material cost swings that can affect margins if not managed through pricing or hedging.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"3_Sustaining_the_Pace_of_Margin_Expansion\"><\/span><strong>3. Sustaining the Pace of Margin Expansion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>With EBITDA margin already up meaningfully this quarter, sustaining further expansion at the same pace may become more challenging in coming quarters.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Jubilant Ingrevia Q1 results FY27 show net profit up 40.9% at Rs 105.8 crore with revenue up 25.2% and the EBITDA margin expanding to 15.3%, a broad based beat across the specialty chemicals business. Investors should track margin sustainability into FY27 and consult a SEBI-registered advisor before acting on the numbers.<\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Jubilant_Ingrevia_Q1_Results_FY27\"><\/span><strong>Frequently Asked Questions on Jubilant Ingrevia Q1 Results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"When_were_the_Jubilant_Ingrevia_Q1_results_FY27_announced\"><\/span><strong>When were the Jubilant Ingrevia Q1 results FY27 announced?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Jubilant Ingrevia Q1 results FY27 were announced on Wednesday, 22 July 2026, for the quarter ended 30 June 2026, on a consolidated basis.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_PAT_in_the_Jubilant_Ingrevia_Q1_results_FY27\"><\/span><strong>What is the PAT in the Jubilant Ingrevia Q1 results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The consolidated PAT in the Jubilant Ingrevia Q1 results FY27 stood at Rs 105.8 crore, up 40.9% from Rs 75.1 crore in Q1 FY26.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_revenue_in_the_Jubilant_Ingrevia_Q1_results_FY27\"><\/span><strong>What was the revenue in the Jubilant Ingrevia Q1 results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue in the Jubilant Ingrevia Q1 results FY27 stood at Rs 1,300 crore, up 25.2% from Rs 1,038 crore in Q1 FY26.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_EBITDA_margin_in_the_Jubilant_Ingrevia_Q1_results_FY27\"><\/span><strong>What was the EBITDA margin in the Jubilant Ingrevia Q1 results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The EBITDA margin in the Jubilant Ingrevia Q1 results FY27 expanded to 15.3% from 13.7% in Q1 FY26, with EBITDA up 39.3% to Rs 198.4 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_businesses_does_Jubilant_Ingrevia_operate\"><\/span><strong>What businesses does Jubilant Ingrevia operate?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The company operates across specialty chemicals, nutrition and health solutions, and life science chemicals segments.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_did_the_share_price_react_to_the_Jubilant_Ingrevia_Q1_results_FY27\"><\/span><strong>How did the share price react to the Jubilant Ingrevia Q1 results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Jubilant Ingrevia share price fell 2.32% to Rs 746.10 on the NSE after the Jubilant Ingrevia Q1 results FY27.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_the_stock_a_good_buy_after_the_Jubilant_Ingrevia_Q1_results_FY27\"><\/span><strong>Is the stock a good buy after the Jubilant Ingrevia Q1 results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Jubilant Ingrevia Q1 results FY27 show a broad based beat with accelerating growth down the P&amp;L, though chemicals sector cyclicality is a factor to weigh. This article is for educational purposes only. Consult a SEBI-registered advisor before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Where_can_I_verify_the_Jubilant_Ingrevia_Q1_results_FY27\"><\/span><strong>Where can I verify the Jubilant Ingrevia Q1 results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The official filings for the June 2026 quarter are available on the NSE and BSE websites, and the stock can be tracked on the Univest app.<\/p>\n<div class=\"faq-schema\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Jubilant Ingrevia Q1 results FY27: net profit rises 40.9% to Rs 105.8 crore on 25.2% revenue growth, with the EBITDA margin expanding to 15.3% from 13.7%. Stock down 2.32%.<\/p>\n","protected":false},"author":35,"featured_media":164831,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802],"class_list":["post-164774","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1784715966:29"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["81"],"rank_math_title":["Jubilant Ingrevia Q1 Results FY27: PAT Up 40.9%"],"rank_math_description":["Jubilant Ingrevia Q1 results FY27: PAT up 40.9% to Rs 105.8 Cr, revenue up 25.2%, EBITDA margin expands to 15.3%. Check full highlights and analysis here."],"rank_math_focus_keyword":["Jubilant Ingrevia Q1"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_thumbnail_id":["164831"],"_edit_last":["29"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["29399"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/07\/Jubilant-Ingrevia-Q1-Results-FY27-Net-Profit-Rises-40.9-to-Rs-105.8-Crore-on-Strong-Specialty-Chemicals-Demand.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/164774","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=164774"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/164774\/revisions"}],"predecessor-version":[{"id":164833,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/164774\/revisions\/164833"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/164831"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=164774"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=164774"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=164774"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}